BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17312857)

  • 1. Comparison of polymethoxyethylacrylate-coated circuits with leukocyte filtration and reduced heparinization protocol on heparin-bonded circuits in different risk cohorts.
    Gunaydin S; McCusker K; Vijay V; Isbir S; Sari T; Onur MA; Gurpinar A; Sezgin A; Sargon MF; Tezcaner T; Zorlutuna Y
    Perfusion; 2006 Nov; 21(6):329-42. PubMed ID: 17312857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical performance and biocompatibility of hyaluronan-based heparin-bonded extracorporeal circuits in different risk cohorts.
    Gunaydin S; McCusker K; Sari T; Onur MA; Zorlutuna Y
    Interact Cardiovasc Thorac Surg; 2010 Mar; 10(3):371-6. PubMed ID: 20026488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization.
    Gunaydin S; Farsak B; McCusker K; Vijay V; Sari T; Onur MA; Gurpinar A; Zorlutuna Y
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical performance and biocompatibility of novel hyaluronan-based heparin-bonded extracorporeal circuits.
    Gunaydin S; Mccusker K; Vijay V
    J Extra Corpor Technol; 2005 Sep; 37(3):290-5. PubMed ID: 16350383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical effects of leukofiltration and surface modification on post-cardiopulmonary bypass atrial fibrillation in different risk cohorts.
    Gunaydin S; Ayrancioglu K; Dikmen E; Mccusker K; Vijay V; Sari T; Tezcaner T; Zorlutuna Y
    Perfusion; 2007 Jul; 22(4):279-88. PubMed ID: 18181517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and biomaterial evaluation of a new condensed dual-function extracorporeal circuit in reoperation for coronary artery bypass surgery.
    Gunaydin S; McCusker K; Vijay V
    Int J Artif Organs; 2009 Nov; 32(11):802-10. PubMed ID: 20020412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of leukocyte filtration as an alternative anti-inflammatory strategy to aprotinin in high-risk patients undergoing coronary revascularization.
    Farsak B; Gunaydin S; Yildiz U; Sari T; Zorlutuna Y
    Surg Today; 2012 Apr; 42(4):334-41. PubMed ID: 22068670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy of leukofiltration on cardiopulmonary bypass related inflammatory response: Fact or Foe?
    Kiliç D; Gunaydin S; Kisa U; Sari T; Deveci O; Zorlutuna Y
    Inflamm Res; 2009 Jun; 58(6):292-7. PubMed ID: 19266265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical performance and biocompatibility of poly(2-methoxyethylacrylate)-coated extracorporeal circuits.
    Gunaydin S; Farsak B; Kocakulak M; Sari T; Yorgancioglu C; Zorlutuna Y
    Ann Thorac Surg; 2002 Sep; 74(3):819-24. PubMed ID: 12238845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of minimized extracorporeal circulation in high-risk coronary revascularization: impact on air handling, inflammation, hemodilution and myocardial function.
    Gunaydin S; Sari T; McCusker K; Schonrock U; Zorlutuna Y
    Perfusion; 2009 May; 24(3):153-62. PubMed ID: 19755462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronan based heparin free coated open and closed extracorporeal circuits for high risk coronary revascularization.
    Gunaydin S; Ucar HI; Serter T; McCusker K; Ozcelik G; Salman N; Yorgancioglu AC
    J Extra Corpor Technol; 2010 Dec; 42(4):286-92. PubMed ID: 21313926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-coated extracorporeal circulation in combination with low dose systemic heparinization reduces early postoperative blood loss in cardiac surgery.
    Mirow N; Zittermann A; Koertke H; Maleszka A; Knobl H; Coskun T; Kleesiek K; Koerfer R
    J Cardiovasc Surg (Torino); 2008 Apr; 49(2):277-84. PubMed ID: 18431350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biocompatibility of heparin-coated cardiopulmonary bypass circuits in coronary patients with left ventricular dysfunction is superior to PMEA-coated circuits.
    Kutay V; Noyan T; Ozcan S; Melek Y; Ekim H; Yakut C
    J Card Surg; 2006; 21(6):572-7. PubMed ID: 17073955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biocompatibility of poly2methoxyethylacrylate coating for cardiopulmonary bypass.
    Noguchi M; Eishi K; Tada S; Yamachika S; Hazama S; Izumi K; Tanigawa K
    Ann Thorac Cardiovasc Surg; 2003 Feb; 9(1):22-8. PubMed ID: 12667126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory response after coronary revascularization: off-pump versus on-pump (heparin-coated circuits and poly2methoxyethylacrylate-coated circuits).
    Hazama S; Eishi K; Yamachika S; Noguchi M; Ariyoshi T; Takai H; Odate T; Matsukuma S; Onohara D; Yanatori M
    Ann Thorac Cardiovasc Surg; 2004 Apr; 10(2):90-6. PubMed ID: 15209550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low dose systemic heparinization combined with heparin-coated extracorporeal circulation. Effects related to platelets.
    Mirow N; Brinkmann T; Minami K; Tenderich G; Schulte-Eistrup S; Kleesiek K; Körfer R
    J Cardiovasc Surg (Torino); 2001 Oct; 42(5):579-85. PubMed ID: 11562580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy of two-phase leukocyte filtration in high-risk patients undergoing coronary revascularization with cardiopulmonary bypass.
    Gunaydin S; Modine T; Sari T; Zorlutuna Y; Gourlay T
    J Extra Corpor Technol; 2009 Sep; 41(3):149-56. PubMed ID: 19806797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of heparin-coated circuits with full heparin dose strategy.
    Sinci V; Kalaycioglu S; Gunaydin S; Imren Y; Gokgoz L; Soncul H; Ersoz A
    Ann Thorac Cardiovasc Surg; 1999 Jun; 5(3):156-63. PubMed ID: 10413761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
    Muehrcke DD; McCarthy PM; Kottke-Marchant K; Harasaki H; Pierre-Yared J; Borsh JA; Ogella DA; Cosgrove DM
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin-coated circuits (Duraflo II) with reduced versus full anticoagulation during coronary artery bypass surgery.
    Ovrum E; Tangen G; Oystese R; Ringdal MA; Istad R
    J Card Surg; 2003; 18(2):140-6. PubMed ID: 12757341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.